INS and type 2 diabetes mellitus: Data from the electronic medical records of a cohort of 13,352,550 patients from 1709 primary care centers in the United Kingdom followed between March and April 2020 raise particular concern over the considerable reduction (77–84%) in testing of glycated hemoglobin and in the prescription of metformin and insulin, especially in older persons with T2D [34].